1. Which of the following timeframes is approved for receipt of a second COVID-19 booster if the patient has already received a first booster injection?

2. Which of the following monoclonal antibodies is currently authorized for treatment of BA.2 COVID-19 variant?

3. As early as June 2022, which of the following manufacturers may gain FDA authorization for COVID-19 vaccines in children aged 6 months to 6 years?

4. Which of the following outcomes regarding ivermectin was found in a recent New England Journal of Medicine study with regard to treatment of COVID-19?

5. Which of the following best characterizes the effect of the BA.2 subvariant versus the previously circulating omicron variant?

Evaluation Questions

6. To what extent did the program meet objective #1?

7. To what extent did the program meet objective #2?

8. Rate the effectiveness of how well the program related to your educational needs:

9. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:

10. Rate the quality of the faculty:

11. Rate the effectiveness and the overall usefulness of the material presented:

12. Rate the appropriateness of the examination for this activity:

13. Rate the effectiveness of how well the activity related to your practice needs:

14. Rate the effectiveness of how well the activity will help you improve patient care:

15. Will the information presented cause you to change your practice?

16. Are you committed to making these changes?

17. As a result of this activity, did you learn something new?

18. What is your practice setting or area of practice?

19. How many years have you been in practice?

« Return to Activity